- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 27 May 2023 - 2 Jun 2023
RESEARCH TYPE:
Basic Science
Animal Studies, Neurobiology, Pharmacology/Drug Development
PAIN TYPE:
Orofacial/Head Pain
2023 May 01
Invest Ophthalmol Vis Sci
64
5
Patients with dry eye disease (DED) sometimes complain of ocular pain. DED-related ocular pain has many similarities with neuropathic pain. Mirogabalin, a novel ligand for the α2δ subunit of voltage-gated calcium channels, is approved for treating neuropathic pain in Japan. This study aimed to investigate the effect of mirogabalin on hyperalgesia and chronic ocular pain in a rat DED model.